Eli Lilly
4,414 hedge funds and large institutions have $847B invested in Eli Lilly in 2025 Q4 according to their latest regulatory filings, with 712 funds opening new positions, 1,695 increasing their positions, 1,607 reducing their positions, and 109 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.87% more ownership
Funds ownership: 80.78% → 83.65% (+2.9%)
5% more repeat investments, than reductions
Existing positions increased: 1,695 | Existing positions reduced: 1,607
3% more call options, than puts
Call options by funds: $17.2B | Put options by funds: $16.7B
Holders
4,414
Holding in Top 10
483
Calls
$17.2B
Puts
$16.7B
Top Buyers
| 1 | +$3.86B | |
| 2 | +$2.61B | |
| 3 | +$1.57B | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.48B |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.37B |
Top Sellers
| 1 | -$3.16B | |
| 2 | -$1.46B | |
| 3 | -$1.15B | |
| 4 |
Edgewood Management
Greenwich,
Connecticut
|
-$883M |
| 5 |
Goldman Sachs
New York
|
-$674M |
